Inventor · disambiguated record
Douglas A. Lauffenburger
Also filed as: LAUFFENBURGER DOUGLAS · LAUFFENBURGER DOUGLAS A
13 granted patents·6 pending applications·218 citations·filing 2001–2018
91Inventor score
Top patents by PatentIndex Score
19 records- 0196US8349311B2Mutant interleukin-2 (IL-2) polypeptidesMASSACHUSETTS INST TECHNOLOGY·Filed 2011·Granted Jan 8, 2013·40 cites·21 claims
- 0296US7951360B2Mutant interleukin-2 (IL-2) polypeptidesMASSACHUSETTS INST TECHNOLOGY·Filed 2009·Granted May 31, 2011·45 cites·18 claims
- 0395US7569215B2Mutant interleukin-2 (IL-2) polypeptidesMASSACHUSETTS INST TECHNOLOGY·Filed 2004·Granted Aug 4, 2009·89 cites·18 claims
- 0486US6946548B2G-CSF analog compositions and methodsMASSACHUSETTS INST TECHNOLOGY·Filed 2001·Granted Sep 20, 2005·28 cites·10 claims
- 0578US7371370B2Methods of using G-CSF analog compositionsMASSACHUSETTS INST TECHNOLOGY·Filed 2004·Granted May 13, 2008·10 cites·5 claims
- 0671US7402304B2Methods of using G-CSF analog compositionsMASSACHUSETTS INST TECHNOLOGY·Filed 2005·Granted Jul 22, 2008·1 cites·4 claims
- 0769US6790628B2Method for screening analogs of G-CSFMASSACHUSETTS INST TECHNOLOGY·Filed 2001·Granted Sep 14, 2004·4 cites·5 claims
- 0863US10028958B2Methods of treating cancer with a combination of selected MEK1/2 and AXL inhibitorsMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Jul 24, 2018·1 cites·21 claims
- 0962US2007274991A1Treatment of tumors expressing mutant EGF receptorsWAY JEFFREY C·Filed 2007·Application pending·0 cites
- 1059US10928397B2Methods involving MenaINV in screening for inhibitors of cancer invasion and metastasisMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Feb 23, 2021·0 cites·14 claims
- 1159US2007009972A1Epidermal growth factor receptor polypeptides and antibodiesCHAO GINGER·Filed 2006·Application pending·0 cites
- 1258US2009311803A1Treatment Of Tumors Expressing Mutant EGF ReceptorsWAY JEFFREY C·Filed 2009·Application pending·0 cites
- 1355US2009137784A1Epidermal Growth Factor Receptor Polypeptides and AntibodiesCHAO GINGER·Filed 2009·Application pending·0 cites
- 1454US9683231B2RNAi-based method of drug screening and characterizationJIANG HAI·Filed 2011·Granted Jun 20, 2017·0 cites·30 claims
- 1552US10114023B2Method of enhancing the efficacy of anti-hepatocyte growth factor receptor breast cancer therapy by administering an inhibitor of menaINVMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Oct 30, 2018·0 cites·4 claims
- 1649US2007009923A1Use of bayesian networks for modeling cell signaling systemsUNIV LELAND STANFORD JUNIOR·Filed 2006·Application pending·0 cites
- 1747US9670486B2RNAi-based method of screening and characterizing drug combinationsPRITCHARD JUSTIN·Filed 2011·Granted Jun 6, 2017·0 cites·27 claims
- 1845US11408885B2Compositions and multiplex assays for characterizing active proteases and their inhibitorsMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Aug 9, 2022·0 cites·13 claims
- 1933US2017168056A1Methods and compositions for detecting and modulating cancer cellsMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Douglas A. Lauffenburger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →